PharmChem
(OTC) PCHM
PharmChem Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$6.22M
Net Income (TTM)
$1.49M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
PCHM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout PharmChem
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
9
CEO
Thompson Clark
Website
www.pharmchek.comHeadquarters
Fort Worth, TX 76118, US
PCHM Financials
Key Financial Metrics (TTM)
Gross Margin
64%
Operating Margin
24%
Net Income Margin
18%
Return on Equity
25%
Return on Capital
31%
Return on Assets
19%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
2.04%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$3.88M
Operating Income
$1.66M
EBITDA
$1.74M
Operating Cash Flow
$1.31M
Capital Expenditure
$2.56K
Free Cash Flow
$1.30M
Cash & ST Invst.
$1.63M
Total Debt
$50.63K
PharmChem Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.58M
+9.2%
Gross Profit
$1.01M
+14.9%
Gross Margin
64.22%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
9
N/A
Net Income
$271.89K
+71.7%
EBITDA
$368.10K
+75.0%
Quarterly Fundamentals
Net Cash
$1.97M
+14.1%
Accounts Receivable
$696.87K
-1.9%
Inventory
$165.37K
-34.0%
Long Term Debt
$13.27K
-69.5%
Short Term Debt
$30.23K
+10.3%
Return on Assets
18.52%
N/A
Return on Invested Capital
30.51%
N/A
Free Cash Flow
$389.35K
+69.5%
Operating Cash Flow
$400.40K
+73.8%